8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2018 / Intervention trial with matched historical controls
Obese participants (n = 23) adhered to an 8-h time-restricted feeding regimen (ad libitum feeding 10:00 to 18:00 h, water fasting 18:00 to 10:00 h) for 12 weeks, compared against 23 matched historical controls. Over 12 weeks, body weight decreased by -2.6% ± 0.5 and energy intake by -341 ± 53 kcal/d relative to controls (P < 0.05). Systolic blood pressure also fell (-7 ± 2 mm Hg vs controls, P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine did not differ significantly between groups.
Gabel K, Hoddy KK, Haggerty N, et al. Nutr Healthy Aging, 2018. PMID 29951594
2018 / Randomized controlled trial
In an eight-week resistance training trial with caloric surplus, men consuming a ketogenic diet showed reduced fat mass (-0.8 kg, 95% CI -1.6 to -0.1) and visceral adipose tissue (-96.5 g, 95% CI -159.0 to -34.0). Neither total weight nor muscle mass increased significantly in the ketogenic group. Conversely, the non-ketogenic diet group gained both body weight (0.9 kg) and muscle mass (1.3 kg, 95% CI 0.5 to 2.2).
Vargas S, Romance R, Petro JL, et al. J Int Soc Sports Nutr, 2018. PMID 29986720
2018 / Randomized, placebo-controlled, double-blind parallel trial
Forty sedentary, obese men aged 40-70 years were randomized to receive 12 weeks of nicotinamide riboside (NR, 1000 mg twice daily) or placebo. NR supplementation did not improve insulin sensitivity, endogenous glucose production, glucose disposal, or glucose oxidation. Furthermore, NR had no effect on resting energy expenditure, lipolysis, lipid oxidation, or body composition. No serious adverse events occurred and safety blood tests remained normal.
Dollerup OL, Christensen B, Svart M, et al. Am J Clin Nutr, 2018. PMID 29992272
2018 / Randomized controlled trial
A trial randomized 46 overweight and obese women to an isoenergetic diet either supplemented with or free of baru almonds for 8 weeks. Compared with the control diet, consuming baru almonds reduced waist circumference by 2.45 cm (95% CI, -3.90 to -0.23; P = 0.03) and cholesteryl ester transfer protein expression by 0.23 mcg/mL (95% CI, -1.24 to -0.08; P = 0.03). High-density lipoprotein concentrations also increased by 4.82 mg/dL (95% CI, 0.03 to 8.88; P = 0.04).
de Souza RGM, Gomes AC, de Castro IA, et al. Nutrition, 2018. PMID 30086484
2018 / Randomized 3x3 crossover trial
A randomized 3x3 crossover study in 26 healthy overweight adults evaluated gut hormone responses and appetite sensations across three lunch test meals consumed one week apart: control, isoenergic avocado inclusive, and energy increased avocado added (AA). A decrease in the 3-hour GLP-1 area under the curve was observed with the AA meal compared to the control meal (P = 0.03). Across meals, PYY3-36 and GIP were negatively associated with hunger, desire, and amount to eat, and positively associated with fullness, satisfaction, and composite visual analog scale (VAS) score (all P < 0.001). GLP-1 was negatively associated with hunger and positively associated with satisfaction and composite VAS score (all P < 0.05).
Haddad E, Wien M, Oda K, et al. Eat Behav, 2018. PMID 30096700
2018 / Randomized controlled trial
Researchers analyzed adipose tissue and skeletal muscle obtained from humans after one night of sleep loss and after one full night of sleep. Acute sleep loss was found to alter genome-wide DNA methylation in adipose tissue, along with tissue-specific transcriptomic, protein, and metabolite changes partially reflected in blood. Inflammation signatures were observed in both tissues, whereas circadian clock alterations were detected only in skeletal muscle alongside molecular signatures suggestive of muscle breakdown contrasting with an anabolic adipose tissue signature.
Cedernaes J, Schönke M, Westholm JO, et al. Sci Adv, 2018. PMID 30140739
2018 / Randomized controlled trial
Researchers randomized inactive obese patients with type 2 diabetes into three experimental diet groups (low-carbohydrate [LCD], low-fat [LFD], high-fat [HFD]; n=11 each) and a normal diet control group (n=9) over 24 weeks combining diets with 12 weeks of cycle-ergometer HIIT. After 24 weeks, the highest percentage improvements were seen in LCD for glucose (-34.76%), cholesterol (-33.35%), HDL (+41.81%), triglycerides (-40.71%), and weight (-12.49%). The highest percentage reductions in IL-6 (-32.10%), resistin (-28.29%), and leptin (-53.92%) occurred in the LCD group, while LFD showed the largest improvements in TNF-alpha (-48.06%), FGF21 (+55.30%), and adiponectin (+42.32%).
Asle Mohammadi Zadeh M, Kargarfard M, Marandi SM, et al. J Diabetes Metab Disord, 2018. PMID 30918861
2017 / Randomized double-blind placebo-controlled trial
Seventy patients with non-alcoholic fatty liver disease were randomized to receive 1,200 mg daily of Chlorella vulgaris or placebo for 8 weeks. Weight reduction was significantly greater in the supplemented arm compared to placebo. Between-group differences in mean changes were significant for serum glucose and TNF-α after adjusting for baseline values and insulin (reported adjusted P-values: 0.014, 0.005, 0.014), but not for other measured outcomes.
Ebrahimi-Mameghani M, Sadeghi Z, Abbasalizad Farhangi M, et al. Clin Nutr, 2017. PMID 27475283
2017 / Comparative crossover trial
Researchers evaluated the effect of no mouthwash, a water mouthwash, and a menthol mouthwash on crisp aftertaste perception and appetite. In the appetite study with 36 subjects, the water mouthwash did not alter desire, liking, hunger, thirst, or ad libitum intake. In contrast, the menthol mouthwash significantly reduced crisp desire, liking, hunger, and thirst, and lowered ad libitum crisp intake by 29% over a 12-minute period.
Hutchings SC, Horner KM, Dible VA, et al. Appetite, 2017. PMID 27663531
2017 / Randomized controlled trial
A randomized, double-blind trial gave 44 overweight or obese adults either yeast beta-glucan (up to 954 mg daily) or placebo for six weeks. Compared to placebo, beta-glucan significantly reduced waist circumference (p = 0.037), blood pressure (p = 0.006), and IL-6 at week six (p = 0.005), while increasing IL-10 (p < 0.001). No significant differences appeared in lipid profiles, liver and kidney markers, or nutrient intake.
Mosikanon K, Arthan D, Kettawan A, et al. J Diet Suppl, 2017. PMID 27715351
2017 / Randomized controlled trial
In an 81-patient randomized trial of overweight and obese women with type 2 diabetes on a weight loss program, replacing diet beverages with water after lunch 5 times per week resulted in greater decreases in weight (-6.40 ± 2.42 kg vs -5.25 ± 1.60 kg; P = .006) and BMI (-2.49 ± 0.92 kg/m2 vs -2.06 ± 0.62 kg/m2; P = .006) over 24 weeks compared to continuing diet beverages. The water group also achieved significantly greater reductions in fasting plasma glucose, fasting insulin, HOMA-IR, and 2-hour postprandial glucose. However, no significant time × group interaction was found for waist circumference, lipid profiles, or HbA1c.
Madjd A, Taylor MA, Delavari A, et al. Diabetes Obes Metab, 2017. PMID 27748014
2017 / Randomized crossover trial
A randomized crossover trial in 30 healthy men compared mid-morning preloads sweetened with aspartame, monk fruit, stevia, or sucrose (65 g). Ad libitum lunch intake was higher after non-nutritive sweetener drinks than sucrose (P = 0.010), leading to full compensation and no difference in total daily energy intake (P = 0.831). Three-hour total area under the curve for glucose (P = 0.960) and insulin (P = 0.216) did not differ among the four beverages.
Tey SL, Salleh NB, Henry J, et al. Int J Obes (Lond), 2017. PMID 27956737
2017 / Double-blind, randomized, placebo-controlled parallel trial
In a double-blind trial, 53 overweight and mild hypercholesterolemic subjects consumed an 80 mL pouch containing 13.5 g of wolfberry extract (WBE) or placebo daily after a meal for 8 weeks. WBE supplementation resulted in a slight but significant decrease in erythrocyte superoxide dismutase activity and an increase in catalase activity. Endogenous DNA damage in lymphocytes, evaluated as the percentage of DNA in the tail via alkaline comet assay, significantly decreased with 8 weeks of WBE. In addition, the proportion of significantly deregulated mRNAs related to oxidative or inflammatory stress was considerably higher in the WBE group.
Lee YJ, Ahn Y, Kwon O, et al. J Agric Food Chem, 2017. PMID 28027641
2017 / Randomized controlled trial
Forty-nine nonhabitual breakfast-eating women were randomized for four weeks to either consume breakfast (at least 15% of daily energy requirement before 8:30 a.m.) or skip breakfast (no energy intake until after 11:30 a.m.). Participants assigned to eat breakfast consumed on average 266 ± 496 more calories per day (P < 0.01) and weighed 0.7 ± 0.8 kg more at the end of the intervention (p < 0.01). No caloric compensation was observed at subsequent meals, and there were no changes in self-reported hunger, satiety, or physical activity compensation.
LeCheminant GM, LeCheminant JD, Tucker LA, et al. Appetite, 2017. PMID 28063876
2017 / Randomized controlled trial
In a 6-month trial involving 77 overweight or obese adults with type 2 diabetes, participants received either Salba-chia or an oat bran control alongside a calorie-restricted regimen. Those receiving Salba-chia achieved greater weight loss (1.9 ± 0.5 kg vs. 0.3 ± 0.4 kg; P = 0.020) and greater waist circumference reductions (3.5 ± 0.7 cm vs. 1.1 ± 0.7 cm; P = 0.027). Salba-chia also produced superior decreases in C-reactive protein (P = 0.045) and increased adiponectin levels (P = 0.022).
Vuksan V, Jenkins AL, Brissette C, et al. Nutr Metab Cardiovasc Dis, 2017. PMID 28089080
2017 / Randomized controlled trial
A 12-week randomized trial assigned 60 overweight and mildly obese adults to consume 45 g daily of either red sorghum or white wheat flaked biscuits within an energy-restricted meal plan. Weight loss was equivalent between groups (P = 0.369), and no differences emerged for glucose, lipids, or inflammatory markers. Both groups showed improvements over time, but red sorghum provided no unique benefits.
Stefoska-Needham A, Beck EJ, Johnson SK, et al. J Am Coll Nutr, 2017. PMID 28135975
2017 / Randomized, placebo-controlled, double-blind parallel trial
A 16-week randomized, placebo-controlled, double-blind trial investigated daily oral supplementation with 1000 mg resveratrol (RSVhigh), 150 mg resveratrol, or placebo in 74 middle-aged men with metabolic syndrome. Resveratrol did not alter circulating hs-CRP, interleukin 6, soluble urokinase plasminogen activator receptor, or inflammatory gene expression in muscle and adipose tissues, and showed no effect on blood pressure, body composition, or glucose and lipid metabolism. However, RSVhigh treatment significantly increased total cholesterol (P < 0.002), LDL cholesterol (P < 0.006), and fructosamine (P < 0.013) compared with placebo.
Kjær TN, Ornstrup MJ, Poulsen MM, et al. J Clin Endocrinol Metab, 2017. PMID 28182820
2017 / Randomized controlled crossover trial
In a randomized trial involving 100 healthy participants, three monthly 5-day cycles of a fasting-mimicking diet reduced body weight, trunk fat, total body fat, blood pressure, and insulin-like growth factor 1. Crossover of the control group resulted in 71 participants finishing three cycles without serious adverse effects. A post hoc analysis revealed that improvements in blood pressure, fasting glucose, cholesterol, triglycerides, and C-reactive protein were greater in individuals initially at risk for disease.
Wei M, Brandhorst S, Shelehchi M, et al. Sci Transl Med, 2017. PMID 28202779
2017 / Double-blind, parallel, randomized placebo-controlled trial
A double-blind, parallel, randomized placebo-controlled trial examined the effects of eight weeks of daily supplementation with six capsules of fruit and vegetable juice concentrate or placebo in 56 overweight and obese adults aged ≥40 years. Following consumption of the juice concentrate, total cholesterol, LDL cholesterol, and plasma TNFα decreased and total lean mass increased, with no change in the placebo group. In participants with high baseline systemic inflammation (serum CRP ≥3.0 mg/mL, n = 16), these effects were greater, though plasma CRP remained unchanged. The concentrate also altered the expression of genes involved in lipogenesis, NF-κB, and AMPK signalling pathways, such as PMVK, ZFAND5, and CAB39.
Williams EJ, Baines KJ, Berthon BS, et al. Nutrients, 2017. PMID 28208713
2017 / Randomized controlled trial
In a multicenter randomized controlled trial, 218 nonobese adults aged 21-51 years followed 25% calorie restriction or ad libitum eating for two years. The calorie restriction group achieved an 11.9% ± 0.7% energy reduction, lowering weight (-7.6 ± 0.3 vs 0.4 ± 0.5 kg), fat mass (-5.4 ± 0.3 vs 0.5 ± 0.4 kg), and fat-free mass (-2.0 ± 0.2 vs -0.0 ± 0.2 kg). Fat-free mass as a percentage of total body weight was higher in the calorie restriction group than controls.
Das SK, Roberts SB, Bhapkar MV, et al. Am J Clin Nutr, 2017. PMID 28228420
2017 / Randomized, double-blind, placebo-controlled trial
Forty-two children aged 7-12 years with BMI >=85th percentile were randomized to receive 8 g/d of oligofructose-enriched inulin or maltodextrin placebo for 16 weeks. Compared with placebo, prebiotics led to significantly higher fullness (P = 0.04) and lower prospective food consumption (P = 0.03) at a week 16 breakfast buffet, and significantly reduced energy intake in 11- to 12-year-olds (P = 0.04) but not 7- to 10-year-olds. Fasting adiponectin (P = 0.04) and ghrelin (P = 0.03) significantly increased with prebiotics compared to placebo. Prebiotic supplementation showed a trend toward reducing BMI z score in intent-to-treat analysis (-3.4%; P = 0.09) and a significant -3.8% reduction in per-protocol analysis (P = 0.043).
Hume MP, Nicolucci AC, Reimer RA Am J Clin Nutr, 2017. PMID 28228425
2017 / Experimental psychology studies (5 studies)
Five studies investigated reactions to experts displaying exemplary behavior in the medical domain. Study 1 found people erroneously believe doctors maintain healthier habits than others, while Study 2 showed doctors advertise these habits. Study 3 demonstrated that individuals who are overweight or obese and concerned about their weight anticipate devaluation from, avoid, and feel less comfortable with fitness-focused doctors. Studies 4 and 5 examined communication strategies for physicians to highlight fitness without alienating weight-sensitive patients.
Howe LC, Monin B J Pers Soc Psychol, 2017. PMID 28240939
2017 / Randomized controlled trial
Thirty-eight adolescents with overweight or obesity receiving a weight-reducing intervention were randomized to receive additional advice and behavioral support to drink 8 cups of water per day or no water advice. At 6 months, self-reported water intake increased more in the water group (difference between groups, 1.6 cups per day [95% CI, 0.2 to 3.0]; P = .03). However, the 6-month change in body mass index z score did not differ between the water group and the control group (between-group difference, -0.0 [95% CI, -0.1 to 0.1]; P = .88). Despite intensive behavioral supports, few adolescents met the 8 cups per day target.
Wong JMW, Ebbeling CB, Robinson L, et al. JAMA Pediatr, 2017. PMID 28264082
2017 / Randomised, double-blind, placebo-controlled crossover trial
In a randomised, double-blind, placebo-controlled crossover trial, 30 subjects with obesity received 12 weeks of once-weekly subcutaneous semaglutide (dose-escalated to 1.0 mg) or placebo. Semaglutide led to a lower ad libitum energy intake during lunch (-1255 kJ; P < .0001), the evening meal (P = .0401), and snacks (P = .0034), producing a 24% reduction in total daily ad libitum energy intake (-3036 kJ; P < .0001). Semaglutide also improved fasting appetite suppression scores, reduced hunger, cravings, and preference for high-fat foods, and reduced mean body weight by 5.0 kg predominantly from fat mass, with no difference in lean-mass-adjusted resting metabolic rate.
Blundell J, Finlayson G, Axelsen M, et al. Diabetes Obes Metab, 2017. PMID 28266779